Atezolizumab and Platinum Plus Pemetrexed With or Without Bevacizumab for Metastatic Nonsquamous Non–Small Cell Lung CancerYoshimasa Shiraishi, Isamu Okamoto, Kazumi Nishino et al.|JAMA Oncology|2023Cited by 52
A phase II study of first-line afatinib for patients aged ≥75 years with EGFR mutation-positive advanced non-small cell lung cancer: North East Japan Study Group trial NEJ027Yuji Minegishi, Akihiko Gemma, Ou Yamaguchi et al.|BMC Cancer|2021Cited by 18
Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA StudyYasunori Murata, Nobuhiko Seki, Shigeru Tanzawa et al.|JTO Clinical and Research Reports|2023Cited by 5
Clinical impact of hypomagnesemia induced by necitumumab plus cisplatin and gemcitabine treatment in patients with advanced lung squamous cell carcinoma: a subanalysis of the NINJA studyShigeru Tanzawa, Nobuhiko Seki, Hiroshige Yoshioka et al.|Therapeutic Advances in Medical Oncology|2025Cited by 3